1. National Institute on Drug Abuse (2019) Opioid overdose crisis. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis. Accessed Jan 2019
2. Alderks CE (2017) Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003–2015 (update) The CBHSQ report: August 22, 2017. Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration, Rockville, MD
3. Gray A (2007) Department of Therapeutics and Medicines Center for the AIDS Programme of Research in South Africa Congella, South Africa
4. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene. Nature 383:819
5. Law P-Y, Wong YH, Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389–430